Unusual presentation of extranodal diffuse large B-cell lymphoma in a solid-organ recipient during long-term immunosuppressive treatment.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 24 8 2021
medline: 15 12 2021
entrez: 23 8 2021
Statut: ppublish

Résumé

Posttransplant lymphoproliferative disorders (PTLDs) refer to a group of diseases, including diffuse large B-cell lymphoma (DLBCL), that develop after solid organ transplantation or hematopoietic stem cell transplantation. Extranodal involvement in PTLDs is common. Reports about exclusive bone marrow involvement are rare. A 70-year-old woman, who had undergone kidney transplantation in 2018, was diagnosed with exclusively extranodal, Epstein-Barr virus-negative DLBCL, with bone marrow and spleen involvement, during long-term immunosuppression. She achieved complete remission with combined immunochemotherapy and temporary hold of immunosuppression. This case shows an uncommon clinical presentation of DLBCL, which was challenging to diagnose, being entirely extranodal. The favorable clinical course relied on timely diagnosis and a multidisciplinary approach. Long-term consequences of posttransplant immunosuppression require a high level of suspicion for an appropriate management, aimed at preserving the graft while eradicating the lymphoproliferative disorder.

Identifiants

pubmed: 34423702
doi: 10.1177/03008916211040862
doi:

Substances chimiques

Immunosuppressive Agents 0
Vincristine 5J49Q6B70F
Doxorubicin 80168379AG
Cyclophosphamide 8N3DW7272P
Prednisone VB0R961HZT

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP127-NP130

Auteurs

Chiara Camerini (C)

Hematology Unit, Center for Translational Medicine, Azienda USL Toscana Nord-Ovest, Livorno-Lucca-Viareggio, Italy.

Emanuela Sant'Antonio (E)

Hematology Unit, Center for Translational Medicine, Azienda USL Toscana Nord-Ovest, Livorno-Lucca-Viareggio, Italy.

Alessandro Ginori (A)

Pathology Unit, "Monterosso" Polyspecialistic Center, Carrara, Italy.

Marco Pellegri (M)

Nuclear Medicine Unit, Ospedale San Luca, Lucca, Italy.

Cataldo De Gaudio (C)

Nuclear Medicine Unit, Ospedale San Luca, Lucca, Italy.

Elena Banti (E)

Nuclear Medicine Unit, Ospedale San Luca, Lucca, Italy.

Vincenzo Ciliberti (V)

Nuclear Medicine Unit, Ospedale San Luca, Lucca, Italy.

Manuela Parrini (M)

Nephrology Unit, Ospedale San Luca, Lucca, Italy.

Laura Bozzoli (L)

Nephrology Unit, Ospedale San Luca, Lucca, Italy.

Federico Simonetti (F)

Hematology Unit, Center for Translational Medicine, Azienda USL Toscana Nord-Ovest, Livorno-Lucca-Viareggio, Italy.

Enrico Capochiani (E)

Hematology Unit, Center for Translational Medicine, Azienda USL Toscana Nord-Ovest, Livorno-Lucca-Viareggio, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH